drugset / Trial / NCT00064766

Norplant and Irregular Bleeding/Spotting

NCT00064766

RandomizedFactorialDouble-blindTreatment

Summary

Irregular or prolonged menstrual bleeding and/or spotting are common side effects in patients using progestin-only hormonal contraception such as levonorgestrel implants (Norplant). Doxycycline, a drug approved by the Food and Drug Administration (FDA) to treat gum disease, may reduce the occurrence of uterine bleeding and spotting in women who use Norplant. This study will evaluate the effects of doxycycline on uterine bleeding/spotting in women using Norplant.

Timeline

Start
2003-02
Primary completion
Completion
2005-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxycycline Small molecule 20 mg